4.6 Review

Phosphoinositides in autophagy: current roles and future insights

Journal

FEBS JOURNAL
Volume 287, Issue 2, Pages 222-238

Publisher

WILEY
DOI: 10.1111/febs.15127

Keywords

autophagy; lysosome; mTORC1; phosphoinositide; phosphoinositide kinase; phosphoinositide phosphatase

Funding

  1. Department of Defense [W81XWH-19-1-0614]

Ask authors/readers for more resources

Today, the importance of autophagy in physiological processes and pathological conditions is undeniable. Initially, autophagy merely was described as an evolutionarily conserved mechanism to maintain metabolic homeostasis in times of starvation; however, in recent years it is now apparent that autophagy is a powerful regulator of many facets of cellular metabolism, that its deregulation contributes to various human pathologies, including cancer and neurodegeneration, and that its modulation has considerable potential as a therapeutic approach. Different lipid species, including sphingolipids, sterols, and phospholipids, play important roles in the various steps of autophagy. In particular, there is accumulating evidence indicating the minor group of phospholipids called the phosphoinositides as key modulators of autophagy, including the signaling processes underlying autophagy initiation, autophagosome biogenesis and maturation. In this review, we discuss the known functions to date of the phosphoinositides in autophagy and attempt to summarize the kinases and phosphatases that regulate them as well as the proteins that bind to them throughout the autophagy program. We will also provide examples of how the control of phosphoinositides and their metabolizing enzymes is relevant to understanding many human diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Medicine, Research & Experimental

Targeting cancer metabolism by simultaneously disrupting parallel nutrient access pathways

Seong M. Kim, Saurabh G. Roy, Bin Chen, Tiffany M. Nguyen, Ryan J. McMonigle, Alison N. McCracken, Yanling Zhang, Satoshi Kofuji, Jue Hou, Elizabeth Selwan, Brendan T. Finicle, Tricia T. Nguyen, Archna Ravi, Manuel U. Ramirez, Tim Wiher, Garret G. Guenther, Mari Kano, Atsuo T. Sasaki, Lois S. Weisman, Eric O. Potma, Bruce J. Tromberg, Robert A. Edwards, Stephen Hanessian, Aimee L. Edinger

JOURNAL OF CLINICAL INVESTIGATION (2016)

Editorial Material Biochemistry & Molecular Biology

PIP-ing Lipids on Membranes: PTEN Takes the Cake

Archna Ravi, Brooke M. Emerling

MOLECULAR CELL (2017)

Article Biochemistry & Molecular Biology

Phosphatidylinositol-5-Phosphate 4-Kinases Regulate Cellular Lipid Metabolism By Facilitating Autophagy

Mark R. Lundquist, Marcus D. Goncalves, Ryan M. Loughran, Elite Possik, Tarika Vijayaraghavan, Annan Yang, Chantal Pauli, Archna Ravi, Akanksha Verma, Zhiwei Yang, Jared L. Johnson, Jenny C. Y. Wong, Yilun Ma, Katie Seo-Kyoung Hwang, David Weinkove, Nullin Divecha, John M. Asara, Olivier Elemento, Mark A. Rubin, Alec C. Kimmelman, Arnim Pause, Lewis C. Cantley, Brooke M. Emerling

MOLECULAR CELL (2018)

Article Oncology

PTEN Deficiency and AMPK Activation Promote Nutrient Scavenging and Anabolism in Prostate Cancer Cells

Seong M. Kim, Tricia T. Nguyen, Archna Ravi, Peter Kubiniok, Brendan T. Finicle, Vaishali Jayashankar, Leonel Malacrida, Jue Hou, Jane Robertson, Dong Gao, Jonathan Chernoff, Michelle A. Digman, Eric O. Potma, Bruce J. Tromberg, Pierre Thibault, Aimee L. Edinger

CANCER DISCOVERY (2018)

Article Biochemistry & Molecular Biology

Epidermal Growth Factor Activates the Rho GTPase-activating Protein (GAP) Deleted in Liver Cancer 1 via Focal Adhesion Kinase and Protein Phosphatase 2A

Archna Ravi, Shelly Kaushik, Aarthi Ravichandran, Catherine Qiurong Pan, Boon Chuan Low

JOURNAL OF BIOLOGICAL CHEMISTRY (2015)

Editorial Material Cell Biology

ORP5 regulates PI(4)P on the lipid droplet: Novel players on the monolayer

Mike F. Renne, Brooke M. Emerling

JOURNAL OF CELL BIOLOGY (2020)

Article Cell Biology

PI5P4Ks drive metabolic homeostasis through peroxisome-mitochondria interplay

Archna Ravi, Lavinia Palamiuc, Ryan M. Loughran, Joanna Triscott, Gurpreet K. Arora, Avi Kumar, Vivian Tieu, Chantal Pauli, Matthias Reist, Rachel J. Lew, Shauna L. Houlihan, Christof Fellmann, Christian Metallo, Mark A. Rubin, Brooke M. Emerling

Summary: PI5P4Ks phosphorylate PI-5-P to PI-4,5-P2 and play a critical role in maintaining energy balance by regulating lipid trafficking and mitochondrial metabolism; Loss of PI5P4Ks leads to mitochondrial structural and functional abnormalities, exacerbated under nutrient deprivation, ultimately causing cell death; Inhibiting PI5P4Ks results in decreased cell viability in cancer cells and suppressed tumor growth in mouse models.

DEVELOPMENTAL CELL (2021)

Review Biochemistry & Molecular Biology

Expanding role of PI5P4Ks in cancer: A promising druggable target

Gurpreet K. Arora, Lavinia Palamiuc, Brooke M. Emerling

Summary: Cancer cells adapt to microenvironmental stresses but also have vulnerabilities that can be targeted for therapy. PI5P4Ks, a family of stress-regulated kinases, are essential for metabolic adaptation in cancer cells and have a synthetic lethal interaction with the tumor suppressor p53. Understanding the role of PI5P4Ks in cancer signaling has led to the development of specific inhibitors for potential therapeutic interventions.

FEBS LETTERS (2022)

Article Oncology

A Functional Precision Oncology Approach to Identify Treatment Strategies for Myxofibrosarcoma Patients

Chantal Pauli, Lamberto De Boni, Jonathan E. Pauwels, Yanjiang Chen, Lara Planas-Paz, Reid Shaw, Brooke M. Emerling, Carla Grandori, Benjamin D. Hopkins, Mark A. Rubin

Summary: In this study, a functional precision oncology approach was implemented to identify tumor-specific drug sensitivities for patients with rare tumor types such as myxofibro-sarcoma. Comprehensive genomic profiling and high-throughput drug screening were used to identify therapeutic options and validate them in patient-derived xenograft models. Targeting the cell cycle was found to be a powerful approach in these tumors.

MOLECULAR CANCER RESEARCH (2022)

Article Cell Biology

Crucial Players for Inter-Organelle Communication: PI5P4Ks and Their Lipid Product PI-4,5-P2 Come to the Surface

Archna Ravi, Lavinia Palamiuc, Brooke M. Emerling

Summary: While organelles are individual compartments with specialized functions, inter-organelle communication is essential for cellular homeostasis. This communication is mediated by phospholipids on organelle membranes, particularly phosphoinositides like phosphatidylinositol 4,5-bisphosphate (PI-4,5-P-2). This review focuses on the role of non-canonical Type II PIPKs in generating PI-4,5-P-2 and their impact on organelle crosstalk, cellular health, and human diseases.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Review Biotechnology & Applied Microbiology

Beyond PI3Ks: targeting phosphoinositide kinases in disease

John E. Burke, Joanna Triscott, Brooke M. Emerling, Gerald R. Hammond

Summary: This Review describes the structure, function, regulation, and disease roles of clinically relevant PIKs outside of class I PI3Ks, as well as the development of potent and specific small-molecule inhibitors. Phosphoinositide kinases are master regulators of cellular processes and their dysregulation has been implicated in various human diseases. Recent years have seen increased interest in targeting phosphoinositide kinases beyond class I PI3Ks, leading to the clinical development of selective inhibitors. This comprehensive analysis provides an overview of the current understanding and progress in the development of phosphoinositide kinase inhibitors.

NATURE REVIEWS DRUG DISCOVERY (2023)

Article Biochemical Research Methods

Endogenous spacing enables co-processing of microRNAs and efficient combinatorial RNAi

Alexandra M. Amen, Ryan M. Loughran, Chun-Hao Huang, Rachel J. Lew, Archna Ravi, Yuanzhe Guan, Emma M. Schatoff, Lukas E. Dow, Brooke M. Emerling, Christof Fellmann

Summary: Multi-miR is a microRNA-embedded shRNA system that allows simultaneous expression of multiple shRNAs, resulting in robust RNA interference. The developed all-in-one vectors show high sensitivity to activation and resistance to inactivation. This system is demonstrated to be effective in intracranial expression of shRNAs in a glioblastoma model and in abolishing tumor growth in a mouse model of KRAS-mutant cancer through combinatorial synthetic lethality.

CELL REPORTS METHODS (2022)

No Data Available